Overview

Safety of Intrathecal Riluzole in Patients With Amyotrophic Lateral Sclerosis

Status:
NOT_YET_RECRUITING
Trial end date:
2027-01-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the safety and tolerability of intrathecal riluzole in adults with amyotrophic lateral sclerosis.
Phase:
PHASE1
Details
Lead Sponsor:
Brain Trust Bio